NPC(SH:600713)2016-04-22 16:00Financial Performance - Operating revenue for the period reached CNY 6.57 billion, reflecting an 11.48% increase year-on-year[6] - Net profit attributable to shareholders was CNY 49.55 million, a 2.70% increase from the same period last year[6] - Basic and diluted earnings per share were both CNY 0.055, up 1.85% from the previous year[6] - Total revenue for Q1 2016 reached ¥6,572,216,250.79, an increase of 11.5% compared to ¥5,895,675,750.53 in the same period last year[46] - The company's operating revenue for Q1 2016 was CNY 301,057,600.69, a significant increase from CNY 61,219,944.17 in the same period last year, representing a growth of approximately 392.5%[50] - The net profit for Q1 2016 was CNY 61,198,472.94, compared to CNY 58,164,315.26 in Q1 2015, showing an increase of about 3.5%[48] - The total profit for Q1 2016 was CNY 82,550,397.98, up from CNY 77,595,880.78 in the previous year, indicating a growth of approximately 3.9%[48] - The total comprehensive income for Q1 2016 was CNY 60,754,093.29, compared to CNY 59,456,005.66 in the previous year, indicating a growth of approximately 2.2%[48] Assets and Liabilities - Total assets increased by 8.85% to CNY 13.71 billion compared to the end of the previous year[6] - The company's total current assets amounted to approximately 12.38 billion RMB, an increase from 11.29 billion RMB at the beginning of the year[38] - Non-current assets totaled ¥1,706,068,992.21, slightly up from ¥1,702,355,498.53 at the beginning of the year[43] - Current liabilities rose to ¥4,537,273,271.16, compared to ¥3,792,103,922.83, indicating a year-over-year increase of 19.6%[44] - Total liabilities reached ¥4,537,273,271.16, up from ¥3,792,103,922.83, reflecting a growth of 19.6%[44] - Owner's equity decreased slightly to ¥1,994,362,307.40 from ¥2,000,518,539.85, a decline of 0.2%[44] Cash Flow - Cash flow from operating activities showed a negative net amount of CNY -600.56 million, worsening from CNY -292.00 million in the previous year[6] - The net cash flow from operating activities was -¥600,559,015.27, worsening from -¥291,999,996.71 in the previous period[17] - The cash flow from operating activities showed a negative trend, with a net cash flow of -539,744,013.53 RMB compared to -517,794,855.30 RMB previously[57] - Total cash inflow from financing activities was 3,027,147,760.00 RMB, up from 1,770,274,238.00 RMB in the previous period, reflecting increased borrowing and bond issuance[55] - Cash outflow from financing activities totaled 2,389,248,499.62 RMB, compared to 1,354,382,524.42 RMB previously, leading to a net cash flow from financing activities of 637,899,260.38 RMB[55] - The company reported a significant increase in cash received from loans, amounting to 1,430,000,000.00 RMB, compared to 750,400,000.00 RMB in the previous period[54] Shareholder Information - The total number of shareholders at the end of the reporting period was 85,690[11] - The largest shareholder, Nanjing Pharmaceutical Group, held 26.94% of the shares, totaling 241,811,214 shares[11] Investment and Financing Activities - The company plans to invest approximately ¥931,984,07 million in expanding the Hefei logistics center, increasing the total investment to about ¥2,601,984,07 million[20] - The company issued a total of ¥4 billion in short-term financing bonds with a coupon rate of 3.10% for a term of 230 days[23] - The company has registered for a non-public targeted debt financing tool with a total amount of ¥1 billion, valid for two years[26] - The company plans to issue corporate bonds not exceeding 1 billion RMB and medium-term notes not exceeding 950 million RMB[28] - The company is actively communicating with potential investors regarding the non-public issuance of shares[29] Operational Challenges - Cash flow from operating activities showed a negative trend, with a net cash flow of -539,744,013.53 RMB compared to -517,794,855.30 RMB previously[57] - The company experienced a loss of CNY -1.17 million from other non-operating income and expenses[8] - The company's advance receipts decreased by 32.61% from the beginning of the year to a balance of ¥42,672,436.57[14] - Interest payable decreased by 61.79% to ¥5,017,418.61, primarily due to the repayment of short-term financing bonds[14] - The company reported an asset impairment loss of ¥11,603,443.66, an increase of 34.48% compared to the previous period[16] - Investment income dropped by 86.47% to ¥749,728.31, attributed to reduced returns from external investments[16]